Nektar Therapeutics's Options: A Look at What the Big Money is Thinking
Deep-pocketed investors have adopted a bullish approach towards Nektar Therapeutics (NASDAQ:NKTR), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NKTR usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Nektar Therapeutics. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 40% bearish. Among these notable options, 5 are puts, totaling $168,473, and 5 are calls, amounting to $150,313.
Expected Price Movements
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $15.0 to $29.0 for Nektar Therapeutics over the recent three months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Nektar Therapeutics's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Nektar Therapeutics's whale trades within a strike price range from $15.0 to $29.0 in the last 30 days.
Nektar Therapeutics Call and Put Volume: 30-Day Overview
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NKTR | PUT | SWEEP | BULLISH | 11/21/25 | $3.0 | $2.6 | $2.6 | $21.00 | $56.1K | 1.0K | 597 |
| NKTR | CALL | SWEEP | BEARISH | 08/15/25 | $3.6 | $3.1 | $3.1 | $23.00 | $40.3K | 777 | 149 |
| NKTR | PUT | SWEEP | BULLISH | 11/21/25 | $2.75 | $2.6 | $2.6 | $21.00 | $31.9K | 1.0K | 361 |
| NKTR | CALL | TRADE | BEARISH | 08/15/25 | $4.0 | $3.0 | $3.0 | $25.00 | $30.0K | 1.2K | 201 |
| NKTR | CALL | TRADE | BULLISH | 08/15/25 | $3.0 | $2.25 | $2.75 | $26.00 | $27.5K | 78 | 100 |
About Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
After a thorough review of the options trading surrounding Nektar Therapeutics, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Current Position of Nektar Therapeutics
- With a trading volume of 768,388, the price of NKTR is up by 1.39%, reaching $24.82.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 15 days from now.
Professional Analyst Ratings for Nektar Therapeutics
2 market experts have recently issued ratings for this stock, with a consensus target price of $102.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
* Consistent in their evaluation, an analyst from B. Riley Securities keeps a Buy rating on Nektar Therapeutics with a target price of $85.
* An analyst from HC Wainwright & Co. persists with their Buy rating on Nektar Therapeutics, maintaining a target price of $120.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Nektar Therapeutics with Benzinga Pro for real-time alerts.
